e-learning
resources
Berlin 2001
Tuesday 25.09.2001
Interstitial and other respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Meloxicam in treatment of sarcoidosis
E. I. Chmidt, V. N. Adamovitch (Moscow, Russia)
Source:
Annual Congress 2001 - Interstitial and other respiratory diseases
Session:
Interstitial and other respiratory diseases
Session type:
Thematic Poster Session
Number:
2632
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. I. Chmidt, V. N. Adamovitch (Moscow, Russia). Meloxicam in treatment of sarcoidosis. Eur Respir J 2001; 16: Suppl. 31, 2632
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Corticosteroid treatment in sarcoidosis
Source: Eur Respir J 2006; 28: 627-636
Year: 2006
Pentoxifylline in treatment of pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 433s
Year: 2002
Treatment of sarcoidosis – pentoxifylline
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
High-doses glucocorticosteroid treatment in sarcoidosis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 118s
Year: 2007
Combination of pentoxifylline and steroids in sarcoidosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 269s
Year: 2005
Comparison of prednisolone and budesonide in the treatment of pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 80s
Year: 2005
Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Pentoxifylline and reduced doses of steroids combination in pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 110s
Year: 2007
Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005
Efficiency of pentoxifylline different doses in sarcoidosis treatment
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008
Glucocorticosteroid treatment in sarcoidosis: comparison of regimens
Source: Eur Respir J 2003; 22: Suppl. 45, 234s
Year: 2003
Long-term treatment with infliximab in patients with sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis
Source: Eur Respir J 2011; 38: 1145-1150
Year: 2011
Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Rituximab in the treatment of refractory pulmonary sarcoidosis
Source: Eur Respir J 2014; 43: 1525-1528
Year: 2014
Therapy with low dose methotrexate plus diprospan in patient with recalcitrant recidivating sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 541s
Year: 2006
Methotrexate vs azathioprine in chronic sarcoidosis
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012
Infliximab in patients with refractory sarcoidosis: Trough concentrations of infiximab
Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept